LSE:ERGO (Ergomed Plc)

Ergomed Plc is a clinical stage development company, which provides specialist services to the pharmaceutical and biotechnology industries spanning all phases of clinical development, post-approval pharmacovigilance, and medical information. It operates through the following business segments: Clinical Research Services (CRO) and Pharmacovigilance (PV). The CRO segment is engaged in process of developing medical therapies, drugs, and knowledge for safe use in healthcare. The PV segment is involved in the activities relating to the detection, understanding, and prevention of adverse effects or other drug-related problems throughout its lifecycle. The company was founded by Miroslav Reljanovic in 1997 and is headquartered in Guildford, the United Kingdom.